Validation of the low anterior resection syndrome score in finnish patients: preliminary results on quality of life in different lars severity groups.


Journal

Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society
ISSN: 1799-7267
Titre abrégé: Scand J Surg
Pays: England
ID NLM: 101144297

Informations de publication

Date de publication:
Sep 2021
Historique:
pubmed: 20 6 2020
medline: 15 12 2021
entrez: 20 6 2020
Statut: ppublish

Résumé

Low anterior resection syndrome is common after anterior resection for rectal cancer. Its severity can be tested with the low anterior resection syndrome score. We have translated the low anterior resection syndrome score to Finnish, and the aim of this study is to validate the translation. The translated Finnish low anterior resection syndrome score and European Organisation for Research and Treatment of Cancer quality-of-life questionnaire-C30 and QLQ-CR29 questionnaires were sent to 159 surviving patients operated with anterior resection for rectal adenocarcinoma between 2007 and 2014 in a tertiary referral center. Psychometric properties of the translation were evaluated in comparison to quality-of-life scales and in different risk factor groups. In the study, 104 (65%) patients returned the questionnaires. Of these, 56 (54%) had major low anterior resection syndrome, 26 (25%) had minor low anterior resection syndrome, and 22 (21%) had no low anterior resection syndrome. Patients with major low anterior resection syndrome had a significantly lower quality of life and more defecatory symptoms as assessed with the European Organisation for Research and Treatment of Cancer questionnaires compared with those with no low anterior resection syndrome. Patients operated with total mesorectal excision had significantly higher low anterior resection syndrome scores compared with those operated with partial mesorectal excision (median/interquartile range 32/15 and 29/11, respectively, The Finnish low anterior resection syndrome score is a valid test in the assessment of postoperative bowel function and its impact on the quality of life. It can be implemented to use during regular follow-up visits of Finnish-speaking rectal cancer patients.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
Low anterior resection syndrome is common after anterior resection for rectal cancer. Its severity can be tested with the low anterior resection syndrome score. We have translated the low anterior resection syndrome score to Finnish, and the aim of this study is to validate the translation.
MATERIALS AND METHODS METHODS
The translated Finnish low anterior resection syndrome score and European Organisation for Research and Treatment of Cancer quality-of-life questionnaire-C30 and QLQ-CR29 questionnaires were sent to 159 surviving patients operated with anterior resection for rectal adenocarcinoma between 2007 and 2014 in a tertiary referral center. Psychometric properties of the translation were evaluated in comparison to quality-of-life scales and in different risk factor groups.
RESULTS RESULTS
In the study, 104 (65%) patients returned the questionnaires. Of these, 56 (54%) had major low anterior resection syndrome, 26 (25%) had minor low anterior resection syndrome, and 22 (21%) had no low anterior resection syndrome. Patients with major low anterior resection syndrome had a significantly lower quality of life and more defecatory symptoms as assessed with the European Organisation for Research and Treatment of Cancer questionnaires compared with those with no low anterior resection syndrome. Patients operated with total mesorectal excision had significantly higher low anterior resection syndrome scores compared with those operated with partial mesorectal excision (median/interquartile range 32/15 and 29/11, respectively,
CONCLUSIONS CONCLUSIONS
The Finnish low anterior resection syndrome score is a valid test in the assessment of postoperative bowel function and its impact on the quality of life. It can be implemented to use during regular follow-up visits of Finnish-speaking rectal cancer patients.

Identifiants

pubmed: 32552563
doi: 10.1177/1457496920930142
pmc: PMC8551436
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

414-419

Références

J Gastrointest Surg. 2015 Feb;19(2):350-9
pubmed: 25326125
Eur J Oncol Nurs. 2015 Oct;19(5):495-501
pubmed: 25813530
Clin Colorectal Cancer. 2015 Jun;14(2):106-14
pubmed: 25677122
BMJ Open. 2014 Jan 21;4(1):e003374
pubmed: 24448844
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
pubmed: 8433390
Int J Colorectal Dis. 2017 May;32(5):691-697
pubmed: 28130593
Colorectal Dis. 2013 Sep;15(9):1130-9
pubmed: 23581977
Int J Surg. 2018 Aug;56:234-241
pubmed: 29936195
J Clin Epidemiol. 1998 Nov;51(11):953-9
pubmed: 9817112
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv263
pubmed: 29741565
Acta Oncol. 2018 Jun;57(6):735-742
pubmed: 29275667
Ann Surg. 2014 Apr;259(4):728-34
pubmed: 23598379
Dis Colon Rectum. 2014 May;57(5):585-91
pubmed: 24819098
Int J Colorectal Dis. 2018 Jun;33(6):787-798
pubmed: 29541896
Tech Coloproctol. 2016 Apr;20(4):215-20
pubmed: 26754654
Ann Gastroenterol. 2019 Mar-Apr;32(2):185-192
pubmed: 30837792
Colorectal Dis. 2018 Oct;20(10):881-887
pubmed: 29679514
J Clin Epidemiol. 1998 Nov;51(11):913-23
pubmed: 9817108
Int J Colorectal Dis. 2018 Aug;33(8):1063-1069
pubmed: 29696348
Dis Colon Rectum. 2019 Jan;62(1):14-20
pubmed: 30394987
Ann Surg. 2012 May;255(5):922-8
pubmed: 22504191
World J Surg. 2018 Aug;42(8):2660-2667
pubmed: 29450698
Colorectal Dis. 2015 Oct;17(10):908-16
pubmed: 25807963
Eur J Surg Oncol. 2015 Nov;41(11):1493-9
pubmed: 26219852
Int J Colorectal Dis. 1996;11(4):191-5
pubmed: 8876278
Eur J Surg Oncol. 2019 Feb;45(2):174-179
pubmed: 30446261

Auteurs

Anu Carpelan (A)

Department of Digestive Surgery, Turku University Hospital, Kiinamyllynkatu 4-8, Turku, 20520, Finland.

Eeva Elamo (E)

Department of Digestive Surgery, Turku University Hospital, University of Turku, Turku, Finland.

Jukka Karvonen (J)

Department of Digestive Surgery, Turku University Hospital, University of Turku, Turku, Finland.

Pirita Varpe (P)

Department of Digestive Surgery, Turku University Hospital, University of Turku, Turku, Finland.

Sami Elamo (S)

Department of Orthopaedics, Satakunta Central Hospital, Pori, Finland and University of Turku, Turku, Finland.

Tero Vahlberg (T)

Biostatistics, Department of Clinical Medicine, University of Turku, Turku, Finland.

Juha Grönroos (J)

Department of Digestive Surgery, Turku University Hospital, University of Turku, Turku, Finland.

Heikki Huhtinen (H)

Department of Digestive Surgery, Turku University Hospital, University of Turku, Turku, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH